| The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates NI Mazur, D Higgins, MC Nunes, JA Melero, AC Langedijk, N Horsley, ... The Lancet Infectious Diseases 18 (10), e295-e311, 2018 | 419 | 2018 |
| Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics NI Mazur, F Martinón-Torres, E Baraldi, B Fauroux, A Greenough, ... The Lancet Respiratory Medicine 3 (11), 888-900, 2015 | 282 | 2015 |
| Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape NI Mazur, J Terstappen, R Baral, A Bardají, P Beutels, UJ Buchholz, ... The Lancet Infectious Diseases 23 (1), e2-e21, 2023 | 188 | 2023 |
| Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial NM Scheltema, EE Nibbelke, J Pouw, MO Blanken, MM Rovers, ... The Lancet Respiratory Medicine 6 (4), 257-264, 2018 | 161 | 2018 |
| Respiratory Syncytial Virus Network (ReSViNET) Foundation. The respiratory syncytial virus vaccine landscape: lessons from the graveyard and promising candidates NI Mazur, D Higgins, MC Nunes, JA Melero, AC Langedijk, N Horsley, ... Lancet Infect Dis 18 (10), e295-e311, 2018 | 68 | 2018 |
| Breast milk prefusion F immunoglobulin G as a correlate of protection against respiratory syncytial virus acute respiratory illness NI Mazur, NM Horsley, JA Englund, M Nederend, A Magaret, A Kumar, ... The Journal of infectious diseases 219 (1), 59-67, 2019 | 63 | 2019 |
| Respiratory Syncytial Virus Network (ReSViNET). Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics NI Mazur, F Martinón-Torres, E Baraldi, B Fauroux, A Greenough, ... Lancet Respir Med 3 (11), 888-900, 2015 | 54 | 2015 |
| Severity of respiratory syncytial virus lower respiratory tract infection with viral coinfection in HIV-uninfected children NI Mazur, L Bont, AL Cohen, C Cohen, A Von Gottberg, MJ Groome, ... Clinical Infectious Diseases 64 (4), 443-450, 2017 | 53 | 2017 |
| Global respiratory syncytial virus–related infant community deaths NI Mazur, YN Löwensteyn, JE Willemsen, CJ Gill, L Forman, ... Clinical Infectious Diseases 73 (Supplement_3), S229-S237, 2021 | 41 | 2021 |
| Respiratory syncytial virus-related death in children with Down syndrome: the RSV GOLD study YN Löwensteyn, EWEM Phijffer, JVL Simons, NM Scheltema, NI Mazur, ... The Pediatric infectious disease journal 39 (8), 665-670, 2020 | 33 | 2020 |
| South African Severe Acute Respiratory Illness (SARI) Surveillance Group. Severity of respiratory syncytial virus lower respiratory tract infection with viral coinfection in … NI Mazur, L Bont, AL Cohen, C Cohen, A von Gottberg, MJ Groome, ... Clin Infect Dis 64 (4), 443-50, 2017 | 12 | 2017 |
| Vicriviroc resistance decay and relative replicative fitness in HIV-1 clinical isolates under sequential drug selection pressures AMN Tsibris, Z Hu, R Paredes, KE Leopold, O Putcharoen, AL Schure, ... Journal of virology 86 (12), 6416-6426, 2012 | 10 | 2012 |
| RSV prevention in infancy and asthma in later life–Authors' reply NM Scheltema, EE Nibbelke, J Pouw, MO Blanken, MM Rovers, ... The Lancet Respiratory Medicine 6 (7), e33, 2018 | 7 | 2018 |
| Nosocomial RSV-related in-hospital mortality in children< 5 years: a global case series YN Löwensteyn, JE Willemsen, NI Mazur, NM Scheltema, ... The Pediatric Infectious Disease Journal 42 (1), 1-7, 2023 | 6 | 2023 |
| Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol YN Löwensteyn, NI Mazur, H Nair, JE Willemsen, G van Thiel, L Bont BMC infectious diseases 21, 1-10, 2021 | 6 | 2021 |
| Respiratory syncytial virus prevention and asthma in healthy preterm infants: a randomised controlled trial. Lancet Respir Med. 2018; 6 (4): 257-264 NM Scheltema, EE Nibbelke, J Pouw, MO Blanken, MM Rovers, ... Epub 2018/03/04. doi: 10.1016/s2213-2600 (18) 30055-9. PubMed PMID: 29500030, 0 | 6 | |
| Respiratory syncytial virus trials and beyond NI Mazur, JJM van Delden, LJ Bont The Lancet Infectious Diseases 15 (12), 1363-1365, 2015 | 5 | 2015 |
| An ethics framework and practical guidance for post-trial access to an RSV maternal vaccine NI Mazur, LJ Bont, JJM van Delden, SB Omer The Lancet Respiratory Medicine 7 (6), 474-476, 2019 | 3 | 2019 |
| Estimated impact of maternal vaccination on global paediatric influenza-related in-hospital mortality: A retrospective case series YN Löwensteyn, H Nair, MC Nunes, I van Roessel, FS Vernooij, ... EClinicalMedicine 37, 2021 | 2 | 2021 |
| Post-trial access in maternal vaccine trials I Van Roessel, NI Mazur, SK Shah, L Bont, R Van Der Graaf American journal of perinatology 36 (S 02), S41-S47, 2019 | 2 | 2019 |
